News

Junshi Biosciences Announces FDA Approval of Investigational New Drug Application for JS110 (XPO1 inhibitor)

-- the 7th innovative drug in Junshi Biosciences’ pipeline to get IND approval from the US FDASHANGHAI, China, Aug. 25,…

2 years ago

Blueberries Medical Reports 2022 Q2 Financial Results and Provides Corporate and Operations Update

TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of…

2 years ago

Atrion Corporation Announces CFO Succession Plan

ALLEN, Texas, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation. (NASDAQ: ATRI) today announced that its Board of Directors has…

2 years ago

Bicycle Health and Evernorth Team Up to Expand Access to Virtual Opioid Use Disorder Treatment

BOSTON, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Bicycle Health today announced that its high-quality, evidence-based virtual opioid use disorder (OUD)…

2 years ago

Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional Mushroom Supplements and Appoints Chief Financial Officer to its Board of Directors

Deals position Optimi Life nutraceutical brand for international distribution Optimi Life Optimi Life Bundle Optimi Life Optimi Life Optimi Life…

2 years ago

Cannabix Technologies Correlates THC in Breath and Blood using Proprietary Sample Collection and Analysis Hardware in Southern US Study

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety Cannabix August…

2 years ago

Sofwave™ to Showcase SUPERB™ (Synchronous Ultrasound Parallel Beam Technology) Live and In-Person at 5CC International Aesthetic Medical and Dermatology Conference

Sofwave to host showcase booth from September 1-4Facial and neck treatment workshop held on September 2SUPERB neck, skin, and eyebrow…

2 years ago

WIMI Hologram Academy: The Application of AR Technology in Sports

HONG KONG, Aug. 25, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

2 years ago

R1 RCM Announces 10-Year End-to-End Revenue Cycle Management Partnership with St. Clair Health

MURRAY, Utah, Aug. 25, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), announced today a 10-year partnership with…

2 years ago

Oyster Point Pharma to Present Analyses at the Women in Ophthalmology Summer Symposium

PRINCETON, N.J., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on…

2 years ago